Search

Your search keyword '"J. F. Wernicke"' showing total 37 results

Search Constraints

Start Over You searched for: Author "J. F. Wernicke" Remove constraint Author: "J. F. Wernicke" Language undetermined Remove constraint Language: undetermined
37 results on '"J. F. Wernicke"'

Search Results

1. Efficacy and safety of atomoxetine in childhood Attention-Deficit/Hyperactivity Disorder with comorbid Oppositional Defiant Disorder

2. Vagus Nerve Stimulation for Treatment of Partial Seizures: 2. Safety, Side Effects, and Tolerability

3. Vagus Nerve Stimulation for Treatment of Partial Seizures: 1. A Controlled Study of Effect on Seizures

4. Vagus Nerve Stimulation for Treatment of Partial Seizures: 3. Long-Term Follow-Up on First 67 Patients Exiting a Controlled Study

5. Long-term follow-up of 37 patients with refractory partial seizures treated with vagus nerve stimulation

6. Clinical Experience with a Helical Bipolar Stimulating Lead

7. Treatment of Refractory Partial Seizures: Preliminary Results of a Controlled Study

8. SEIZURE RISK IN PATIENTS WITH ADHD TREATED WITH ATOMOXETINE

9. Fibromyalgia syndrome

10. Safety profile of atomoxetine in the treatment of children and adolescents with ADHD

11. Vagus nerve stimulation for the treatment of medically intractable seizures. Results of a 1-year open-extension trial. Vagus Nerve Stimulation Study Group

12. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures

13. Safety and tolerability of the implantable recurrent laryngeal nerve stimulator

14. Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study Group

15. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group

16. Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group

17. Treatment of epilepsy by stimulation of the vagus nerve

18. High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression

19. Fluoxetin 20 mg/Tag: Die empfohlene therapeutisch wirksame Dosis in der Depressionsbehandlung

20. Studien über fixe Dosierung und Sicherheitsprofil von Fluoxetin

21. Approaches for the development of oral drug therapies for erectile dysfunction

22. Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression

23. Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression

24. Vagus Nerve Stimulation for the Treatment of Medically Intractable Seizures

25. The Evidence for 20 mg a day of Fluoxetine as the Optimal Dose in the Treatment of Depression

26. ?-NEUROTOXIN REDUCES NEUROTRANSMITTER STORAGE IN BRAIN SYNAPSES

27. THE MECHANISM OF ACTION OF ?-BUNGAROTOXIN

28. Glial differentiation in dissociated cell cultures of neonatal rat brain: Noncoordinate and density-dependent regulation of oligodendroglial enzymes

29. A Comparison of Fluoxetine Imipramine and Placebo in Patients with Bipolar Depressive Disorder

30. Effect of dose escalation after low-dose fluoxetine therapy

31. Low-dose fluoxetine therapy for depression

33. The side effect profile and safety of fluoxetine

34. The mechanism of action of beta-bungarotoxin

35. A humoral lymphocyte transformation inhibition factor in multiple sclerosis

36. Acid lipase-esterase (4-methylumbelliferyl oleate hydrolase) of white matter localized in oligodendrocyte cell bodies

37. HIGH-DOSE FLUOXETINE - EFFICACY AND ACTIVATING-SEDATING EFFECTS IN AGITATED AND RETARDED DEPRESSION

Catalog

Books, media, physical & digital resources